Traders place an 81.5% probability on no new COVID variant of concern emerging before 2027 because ongoing genomic and wastewater surveillance shows SARS-CoV-2 circulating at stable endemic levels without any strain meeting official criteria for heightened transmissibility, severity, or immune escape. The BA.3.2 sublineage, detected more widely since late 2025 across dozens of countries and U.S. states, carries notable spike mutations but has produced no case surges or hospitalizations exceeding baseline rates through early 2026. Strong population immunity from prior infections and 2025–26 vaccines continues to blunt severe outcomes, keeping the situation far from thresholds that would prompt a new designation. This skin-in-the-game consensus reflects consistent low-risk data rather than any sudden shift.